The increasing power of a few leading drug companies is raising significant concerns worldwide. This pattern towards monopolies frequently contributes to higher prescription charges, restricted development, and obstacles in obtaining vital medications for people across the globe. Experts contend that stronger oversight is necessary to tackle these

India's pharmaceutical landscape presents a complex picture, largely shaped by the substantial influence of a few prominent players. While the sector is often lauded for its generic drug manufacturing capabilities, a closer examination reveals a degree of sector concentration that warrants scrutiny. These incumbent companies, including names like S